Rieckmann P - Search Results

1

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H. Brück W, et al. Among authors: rieckmann p. Ann Neurol. 1995 Nov;38(5):788-96. doi: 10.1002/ana.410380514. Ann Neurol. 1995. PMID: 7486871

2

Multiple sclerosis in the Arabian Gulf countries: a consensus statement.

Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P. Bohlega S, et al. Among authors: rieckmann p. J Neurol. 2013 Dec;260(12):2959-63. doi: 10.1007/s00415-013-6876-4. Epub 2013 Mar 17. J Neurol. 2013. PMID: 23504049 Free PMC article. Review.

3

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.

Comi G, Cook SD, Giovannoni G, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Hamlett AC, Viglietta V, Greenberg SJ. Comi G, et al. Among authors: rieckmann p. J Neurol. 2013 Apr;260(4):1136-46. doi: 10.1007/s00415-012-6775-0. Epub 2012 Dec 21. J Neurol. 2013. PMID: 23263473 Clinical Trial.

4

Symptomatology of MS: results from the German MS Registry.

Stuke K, Flachenecker P, Zettl UK, Elias WG, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Rieckmann P. Stuke K, et al. Among authors: rieckmann p. J Neurol. 2009 Nov;256(11):1932-5. doi: 10.1007/s00415-009-5257-5. Epub 2009 Jul 23. J Neurol. 2009. PMID: 19629565

5

Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.

Rieckmann P, Kruse N, Nagelkerken L, Beckmann K, Miller D, Polman C, Dahlke F, Toyka KV, Hartung HP, Stürzebecher S. Rieckmann P, et al. J Neurol. 2005 May;252(5):526-33. doi: 10.1007/s00415-005-0681-7. J Neurol. 2005. PMID: 15895275 Clinical Trial.

6

Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, Kleinschnitz C, Kleiter I, Lee DH, Limmroth V, Mäurer M, Meuth S, Rieckmann P, Ruck T, Gold R, Linker RA. Huhn K, et al. Among authors: rieckmann p. J Neurol. 2018 Jul;265(7):1521-1527. doi: 10.1007/s00415-018-8871-2. Epub 2018 Apr 25. J Neurol. 2018. PMID: 29696498

7

Future MS care: a consensus statement of the MS in the 21st Century Steering Group.

Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Rieckmann P, et al. J Neurol. 2013 Feb;260(2):462-9. doi: 10.1007/s00415-012-6656-6. Epub 2012 Aug 31. J Neurol. 2013. PMID: 22936203 Free PMC article.

8

The natural history of primary progressive multiple sclerosis.

Koch M, Kingwell E, Rieckmann P, Tremlett H. Koch M, et al. Among authors: rieckmann p. Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f. Neurology. 2009. PMID: 19996074

9

Inflammation in multiple sclerosis: the good, the bad, and the complex.

Martino G, Adorini L, Rieckmann P, Hillert J, Kallmann B, Comi G, Filippi M. Martino G, et al. Among authors: rieckmann p. Lancet Neurol. 2002 Dec;1(8):499-509. doi: 10.1016/s1474-4422(02)00223-5. Lancet Neurol. 2002. PMID: 12849335 Review.

10

A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate.

van der Knaap MS, van der Voorn P, Barkhof F, Van Coster R, Krägeloh-Mann I, Feigenbaum A, Blaser S, Vles JS, Rieckmann P, Pouwels PJ. van der Knaap MS, et al. Among authors: rieckmann p. Ann Neurol. 2003 Feb;53(2):252-8. doi: 10.1002/ana.10456. Ann Neurol. 2003. PMID: 12557294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results